DAA2571 |
Level of miR-20b decreases with age |
Molecular |
T cell |
Human |
MIR20B |
53.3% Decrease miRNA Level |
|
DAA2579 |
Level of miR-206 decreases with age |
Molecular |
T cell |
Human |
MIR206 |
47.4% Decrease miRNA Level |
|
DAA2548 |
Level of miR-19b decreases with age |
Molecular |
T cell |
Human |
MIR19B1 |
63.5% Decrease miRNA Level |
|
DAA2563 |
Level of miR-19a decreases with age |
Molecular |
T cell |
Human |
MIR19A |
49.0% Decrease miRNA Level |
|
DAA2580 |
Level of miR-18b decreases with age |
Molecular |
T cell |
Human |
MIR18B |
39.3% Decrease miRNA Level |
|
DAA2551 |
Level of miR-17 decreases with age |
Molecular |
T cell |
Human |
MIR17 |
63.1% Decrease miRNA Level |
|
DAA2578 |
Level of miR-15b decreases with age |
Molecular |
T cell |
Human |
MIR15B |
29.4% Decrease miRNA Level |
|
DAA2553 |
Level of miR-15a decreases with age |
Molecular |
T cell |
Human |
MIR15A |
78.0% Decrease miRNA Level |
|
DAA2572 |
Level of miR-146b-5p increases with age |
Molecular |
T cell |
Human |
MIR146B |
59.4% Increase miRNA Level |
|
DAA2568 |
Level of miR-125a-5p decreases with age |
Molecular |
T cell |
Human |
MIR125A |
48.2% Decrease miRNA Level |
|
DAA2575 |
Level of miR-106b decreases with age |
Molecular |
T cell |
Human |
MIR106B |
40.4% Decrease miRNA Level |
|
DAA2581 |
Level of miR-101 decreases with age |
Molecular |
T cell |
Human |
MIR101-1 |
49.5% Decrease miRNA Level |
|
DAA2561 |
Level of let-7i decreases with age |
Molecular |
T cell |
Human |
MIRLET7I |
46.9% Decrease miRNA Level |
|
DAA2559 |
Level of let-7f decreases with age |
Molecular |
T cell |
Human |
MIRLET7F1 |
65.6% Decrease miRNA Level |
|
DAA2577 |
Level of let-7c increases with age |
Molecular |
T cell |
Human |
MIRLET7C |
33.6% Increase miRNA Level |
|
DAA944 |
Less antibodies generated |
Physiological |
B cell |
Human |
— |
— |
|
DAA955 |
Interleukin-7 production declines |
Physiological |
stromal cell |
Human |
IL7 |
— |
|
DAA962 |
Interleukin-2 production in response to influenza vaccine declines |
Physiological |
T cell |
Human |
IL2 |
— |
|
DAA975 |
Infiltration at injury site is reduced |
Physiological |
neutrophil |
Human |
— |
— |
|
DAA987 |
Increase in total number of cells |
Physiological |
natural killer cell |
Human |
— |
— |
|
DAA953 |
Increase in cells that are both CD8+ and CD28-null |
Physiological |
T regulatory cell |
Human |
— |
— |
|
DAA961 |
Increased apoptosis associated with Fas and Fas-ligand expression |
Physiological |
T cell |
Human |
FAS |
— |
|
DAA965 |
Incidence of anergia increases |
Physiological |
immune system |
Human |
— |
— |
|
DAA950 |
Immune response to Epstein-Barr virus decreases in cytomegalovirus positive individuals |
Physiological |
immune system |
Human |
— |
— |
|
DAA985 |
Functional decline and decreases in macrophage numbers in bone marrow |
Physiological |
macrophage |
Human |
— |
— |
|